Sun Pharma Stock Slips as Organon Holders Approve Merger
Sun Pharma touched a day high of Rs 1,959.80 on Friday, before slipping into the red, after Organon shareholders approved its buyout. The news behind...
Tag : sun pharma
Sun Pharma Hits 52-Week High on South Africa Drug Nod
Sun Pharma hit a 52-week high of Rs 1,962.70 on the NSE on Wednesday after South Africa approved its generic diabetes drug. The approval came...
Pharma Stocks Fall After Fresh Trump Warning
Pharma stocks such as Sun Pharma, Dr. Reddy’s Labs, and Divi’s Labs plummeted on 26th August. This occurred after US President Donald Trump vowed to...
Shares of Pharmaceutical Companies Slump on Trump’s Plan
Following President Trump’s signing of an Executive Order to boost domestic drug production facilities, leading pharmaceutical exporters to the United States may risk commercial disruption,...
Top 10 Pharmaceutical Companies in India in 2025
India’s pharmaceutical industry is on the rise, with its top companies becoming key players on the global stage. Behind their success lies a blend of...
Sun Pharma Signs Global Licensing Deal for Philogen’s Anti-Cancer Immunotherapy, Shares Down 1%
Shares of Sun Pharmaceutical Industries Ltd. fell by 1% after reaching a day’s high of Rs 1,934.75 on 1st October. This followed the company’s announcement...
LIC Offloads 2% Stake in Sun Pharmaceutical
LIC (Life Insurance Corporation of India), on 14 September, had divested a 2.011% stake in Sun Pharmaceutical Industries Ltd, taking its stake in the company...
Sun Pharma Completes Acquisition of Concert Pharmaceuticals
On Monday, pharmaceutical giant Sun Pharma said it had completed its acquisition of US-based Concert Pharmaceuticals. In January, the Mumbai-based company signed a deal to...
Sensex Falls Over 150 Points in Early Trade, Nifty at 18,650
Benchmark stock indexes opened lower on Monday amid mixed global cues. The BSE Sensex traded 183 points or 0.29% lower at 62,685. In contrast, the...
RIL Among Mutual Fund’s 10 Most Desired Stocks During Earnings Season
Mutual funds ramped up bets on the Mukesh Ambani-led company in October despite an unexpected drop in Reliance Industries (RIL) second-quarter profit. Two other top...